Clinical, virological and immunological features from patients infected with re-emergent avian-origin human H7N9 influenza disease of varying severity in Guangdong province

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Yang, Zi Feng ^a   Mok, Chris Ka Pun ^b   Liu, Xiao Qing ^a   Li, Xiao Bo ^b   He, Jian Feng ^c   Guan, Wen Da ^a   Xu, Yong Hao ^a   Pan, Wei Qi ^a   Chen, Li Yan ^a   Lin, Yong Ping ^a   Wu, Shi Guan ^a   Pan, Si Hua ^a   Huang, Ji Cheng ^b   Ding, Guo Yun ^b   Zheng, Kui ^b   Ke, Chang Wen ^c   Lin, Jin Yan ^c   Zhang, Yong Hui ^c   Lee, Horace Hok Yeung ^d,e   Liu, Wen Kuan ^a   Yang, Chun Guang ^a   Zhou, Rong ^a   Peiris, Joseph Sriyal Malik ^d,e   Li, Yi Min ^a   Chen, Rong Chang ^a   Chen, Ling ^a   Zhong, Nan Shan ^a   more..

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Guangdong Inspection and Quarantine Technology Center   (China)

^c GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; OSELTAMIVIR; PERAMIVIR; ZANAMIVIR; CYTOKINE;

ADULT; AGED; ARTICLE; AVIAN INFLUENZA; CHINA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FLOW CYTOMETRY; HERPES SIMPLEX VIRUS 1; HUMAN; INFLUENZA VIRUS A H7N9 INFECTION; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALVAGE THERAPY; SPUTUM; THROAT CULTURE; TRACHEAL ASPIRATION PROCEDURE; TREATMENT FAILURE; UPREGULATION; VIRUS LOAD; VIRUS REACTIVATION; BLOOD; CLASSIFICATION; COMMUNICABLE DISEASE; EPIDEMIC; FEMALE; GENETICS; INFLUENZA A VIRUS (H7N9); INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEROTYPE; SEVERITY OF ILLNESS INDEX; VIROLOGY;

AVES; HUMAN HERPESVIRUS 1;

ADULT; AGED; CHINA; COMMUNICABLE DISEASES, EMERGING; CYTOKINES; DISEASE OUTBREAKS; FEMALE; HUMANS; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; SEROGROUP; SEVERITY OF ILLNESS INDEX; VIRAL LOAD;

EID: 84923797845     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117846     Document Type: Article

References (24)

1. Chen Y, Liang W, Yang S, Wu N, Gao H, Sheng J, et al. Human infections with the emerging avian influen za A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome. Lancet 2013; 381: 1916-1925 doi: 10.1016/S0140-6736(13)60903-4 PMID: 23623390
2. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, et al. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 2013; 368:1888-97. doi: 10.1056/NEJMoa1304459 PMID: 23577628
3. Lu J, Wu J, Zeng X, Guan D, Zou L, Yi L, et al. Continuing reassortment leads to the genetic diversity of Influenza H7N9 in Guangdong China. J Virol 2014; pii:00630-14.
4. Cheng HW, Li CW, Chan KY, Sham MK. The First Confirmed Case of Human Avian Influenza A(H7N9) in Hong Kong and the Suspension of Volunteer Services: Impact on Palliative Care. J Pain Symptom Manage 2014; pii: S0885-3924 doi: 10.1016/j.jpainsymman.2014.12.002 PMID: 25557112
5. Xiang N, Havers F, Chen T, Song Y, Tu W, Li L, et al. Use of national pneumonia surveillance to describe influenza A(H7N9) virus epidemiology, China, 2004-2013. Emerg Infect Dis 2013; 19:1784-90. doi: 10.3201/eid1911.130865 PMID: 24206646
6. Gao HN, Lu HZ, Cao B, Du B, Shang H, Gan JH, et al. Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med 2013; 368:2277-85. doi: 10.1056/NEJMoa1305584 PMID: 23697469
7. Wang C, Yu H, Horby PW, Cao B, Wu P, Yang S, et al. Comparison of patients hospitalized with influenza A subtypes H7N9, H5N1, and 2009 pandemic H1N1. Clin Infect Dis 2014; 58:1095-103. doi: 10.1093/cid/ciu053 PMID: 24488975
8. ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA 2012; 307:2526-33. doi: 10.1001/jama.2012.5669 PMID: 22797452
9. WHO website. Available: http://www.who.int/influenza/gisrs-laboratory/cnic-serological-diagnosis-hai-a-h7n9-20131220.pdf. Accessed 2015 Jan 23.
10. WHO website. Available: http://www.who.int/influenza/gisrs-laboratory/cnic-serological-diagnosis-microneutralization-a-h7n9.pdf. Accessed 2015 Jan 23.
11. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1; 44 Suppl 2:S27-72. PMID: 17278083
12. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013 Feb; 39(2):165-228. doi: 10.1007/s00134-012-2769-8 PMID: 23361625
13. Hung IF, To KK, Lee CK, Lee KL, Chan K, Yan WW, et al. Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 2011; 52:447-56. doi: 10.1093/cid/ciq106 PMID: 21248066
14. Zhang A, Huang Y, Tian D, Lau EH, Wan Y, Liu X, et al. Kinetics of serological responses in influenza A (H7N9)-infected patients correlate with clinical outcome in China, 2013. Euro Surveill 2013; 18:20657. PMID: 24342519
15. Yu L, Wang Z, Chen Y, Ding W, Jia H, Chan JF, et al. Clinical, virological, and histopathological manifestations of fatal human infections by avian influenza A(H7N9) virus. Clin Infect Dis 2013; 57:1449-57. doi: 10.1093/cid/cit541 PMID: 23943822
16. Shi J, Xie J, He Z, Hu Y, He Y, Huang Q, et al. A detailed epidemiological and clinical description of 6 human cases of avian-origin influenza A (H7N9) virus infection in Shanghai. PLoS One 2013; 8: e77651. doi: 10.1371/journal.pone.0077651 PMID: 24143251
17. Wang XF, Shi GC, Wan HY, Hang SG, Chen H, Chen W, et al. Clinical features of three avian influenza H7N9 virus-infected patients in Shanghai. Clin Respir J 2013; doi: 10.1111/crj.12087 PMID: 24341826
18. Liderot K, Ahl M, Ozenci V. Secondary bacterial infections in patients with seasonal influenza A and pandemic H1N1. Biomed Res Int. 2013; 2013:376219. doi: 10.1155/2013/376219 PMID: 23865050
19. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006; 12:1203-7. PMID: 16964257
20. Wu C, Lu X, Wang X, Jin T, Cheng X, Fang S, et al. Clinical symptoms, immune factors, and molecular characteristics of an adult male in Shenzhen, China infected with influenza virus H5N1. J Med Virol 2013; 85:760-8. doi: 10.1002/jmv.23492 PMID: 23508902
21. Bradley-Stewart A, Jolly L, Adamson W, Gunson R, Frew-Gillespie C, Templeton K, et al. Cytokine responses in patients with mild or severe influenza A(H1N1)pdm09. J Clin Virol 2013; 58:100-7. doi: 10.1016/j.jcv.2013.05.011 PMID: 23790455
22. Chi Y, Zhu Y, Wen T, Cui L, Ge Y, Jiao Y, et al. Cytokine and chemokine levels in patients infected with the novel avian influenza A (H7N9) virus in China. J Infect Dis. 2013; 208:1962-7. doi: 10.1093/infdis/jit440 PMID: 23990573
23. Wang Z, Zhang A, Wan Y, Liu X, Qiu C, Xi X, et al. Early hypercytokinemia is associated with interferon-induced transmembrane protein-3 dysfunction and predictive of fatal H7N9 infection. Proc Natl Acad Sci U S A 2014; 111:769-74. doi: 10.1073/pnas.1321748111 PMID: 24367104
24. Zhou J, Wang D, Gao R, Zhao B, Song J, Qi X, et al. Biological features of novel avian influenza A (H7N9) virus. Nature 2013; 499:500-3. doi: 10.1038/nature12379 PMID: 23823727